We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£595.00
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants and Anorexiants Excluding Amphetamines in Japan
Price data last checked 69 day(s) ago - refreshing...
Price History & Forecast
Last 22 days • 22 data points (No recent data available)
Price Distribution
Price distribution over 22 days • 1 price levels
Price Analysis
Most common price: £595 (22 days, 100.0%)
Price range: £595 - £595
Price levels: 1 different prices over 22 days
Product Specifications
- Format
- paperback
- ASIN
- B01M3PRB75
- Domain
- Amazon UK
- Release Date
- 22 September 2015
- Listed Since
- 13 October 2016
Similar Products You Might Like
98% match
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants Excluding Non-Drug Dietaries for Weight Control in Japan
£595.00
10 Feb 2026
97% match
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants and Anorexiants Excluding Amphetamines in Greater China
£595.00
30 Jan 2026
97% match
The 2016-2021 Outlook for Pharmaceutical Preparations Affecting the Central Nervous System and Sense Organs in Japan
£595.00
28 Jan 2026
96% match
Prescription Narcotic Cough Preparations Outlook in Japan
£595.00
10 Mar 2026
96% match
The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in Japan
£595.00
12 Feb 2026
96% match
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants Excluding Non-Drug Dietaries for Weight Control in the United States
£595.00
15 Feb 2026
96% match
The 2016-2021 Outlook for Pharmaceutical Preparations for Human Use Acting on the Central Nervous System and the Sense Organs in Japan
£595.00
28 Jan 2026
96% match
The 2016-2021 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Japan
£595.00
11 Feb 2026
96% match
The 2016-2021 Outlook for Neurostimulation Devices in Japan
£595.00
27 Jan 2026
96% match
The 2016-2021 Outlook for Prescription Non-Narcotic Cough Preparations and Expectorants in Japan
£595.00
25 Jan 2026
96% match
The 2016-2021 Outlook for Alimentary and Metabolism Pharmaceuticals in Japan
£595.00
24 Jan 2026
96% match
The 2016-2021 Outlook for Narcolepsy Therapeutics in Japan
£595.00
22 Jan 2026
96% match
The 2016-2021 Outlook for Anesthesia Disposables in Japan
£595.00
22 Jan 2026
96% match
The 2016-2021 Outlook for Systemic Antiviral Pharmaceuticals in Japan
£595.00
25 Jan 2026
96% match
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants Excluding Non-Drug Dietaries for Weight Control in Greater China
£595.00
12 Jan 2026
96% match
The 2016-2021 Outlook for Antidepressant Pharmaceuticals in Japan
£595.00
18 Feb 2026
96% match
The 2016-2021 Outlook for Decongestants in Japan
£595.00
27 Jan 2026
96% match
The 2016-2021 Outlook for Effervescent-Type, Suppositories, and Other Internal Analgesics and Antipyretics in Japan
£595.00
12 Jan 2026
96% match
The 2016-2021 Outlook for Antibacterial and Antiseptic Pharmaceuticals in Japan
£595.00
25 Jan 2026
96% match
The 2016-2021 Outlook for Opium and Opium-Derivative Narcotic Internal Analgesic and Antipyretic Pharmaceutical Preparations in Japan
£595.00
23 Feb 2026
96% match
The 2016-2021 Outlook for Anti-Arrhythmic Vasodilator Pharmaceuticals in Japan
£595.00
07 Feb 2026
96% match
The 2016-2021 Outlook for Weight-Loss Medication in Japan
£595.00
23 Jan 2026
95% match
The 2016-2021 Outlook for Scale Inhibitors in Japan
£595.00
20 Jan 2026
95% match
The 2016-2021 Outlook for Diet Aids Containing Local Anesthetics Excluding Non-Drug Dietaries for Weight Control and Bulk-Only Diet Aids in Japan
£595.00
14 Jan 2026